Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Feb 28;11(8):1193-5.
doi: 10.3748/wjg.v11.i8.1193.

Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer

Katarzyna Guzinska-Ustymowicz  1 , Andrzej Kemona
Affiliations

Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer

Katarzyna Guzinska-Ustymowicz et al. World J Gastroenterol. .

Abstract

Aim: To evaluate the significance of transforming growth factor beta (TGF beta) expression, in correlation with histopathological parameters, at the front of invasion in T1 colorectal cancer (CRC) and presence of metastases.

Methods: TGF beta immunohistochemical expression was studied in 34 specimens of colorectal adenocarcinomas (pT1). A three-step avidin-biotinylated immuno-peroxidase (ABCu-NCL) staining technique was performed on 4-mum paraffin-embedded tissue sections with a monoclonal antibody to TGF beta (Novocastra, NCL-TGFB, clone TGFB 17, dilution 1:40).

Results: Seventeen (50%) out of 34 lesions were positive for TGF beta expression. The TGF beta-positive rate in patients with vascular invasion was significantly higher than in those without vascular invasion (11/14 cases, P<0.01, P = 0.005). The TGF beta-positive rate was observed in 91.7% of patients with presence of tumor budding at the front of invasion (11/12 cases, P<0.01, P = 0.0003). A statistically significant correlation was found between the presence of lymph node metastases and positive expression of TGF beta (14/16 cases, P<0.01, P = 0.0001). We also observed that the TGF beta-positive rates in groups with distant and non-distant metastases were 92.8% and 20% respectively, and a significant correlation between TGF beta expression and distant metastasis was shown (P<0.01, P = 0.00003).

Conclusion: The evaluation of TGF beta expression of protein in association with histological parameters can be used as a parameter of the aggressiveness of pT1 CRC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strong cytoplasmic expression of TGF β in neoplastic cells ×200.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer. 1989;63:539–543. - PubMed
    1. Guzińska-Ustymowicz K, Sulkowska M, Famulski W, Sulkowski S. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer. Anticancer Res. 2003;23:649–653. - PubMed
    1. Famulski W, Guzińska-Ustymowicz K, Sulkowska M, Chabowski A, Zalewski B, Piotrowski Z, Stasiak-Barmuta A, Sulkowski S. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer. Folia Histochem Cytobiol. 2001;39 Suppl 2:171–172. - PubMed
    1. Fujiwara T, Stolker JM, Watanabe T, Rashid A, Longo P, Eshleman JR, Booker S, Lynch HT, Jass JR, Green JS, et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol. 1998;153:1063–1078. - PMC - PubMed
    1. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev. 1996;7:93–102. - PubMed

MeSH terms

Substances